OLVIG
AVXL icon

Oliver Lagore Vanvalin Investment Group’s Anavex Life Sciences AVXL Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-748
Closed -$3.81K – 733
2024
Q1 		$3.81K Hold
748
– – ﹤0.01% 543
2023
Q4 		$6.96K Sell
748
-5
-0.7% -$34 ﹤0.01% 476
2023
Q3 		$4.93K Hold
753
– – ﹤0.01% 554
2023
Q2 		$6.12K Hold
753
– – ﹤0.01% 546
2023
Q1 		$6.45K Sell
753
-17
-2% -$170 ﹤0.01% 451
2022
Q4 		$7.13K Buy
+770
New +$8.23K ﹤0.01% 415

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's AVXL Position: Q2 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Anavex Life Sciences (AVXL) in Q2 2024, closing a stake of 748 shares — an estimated $3.81K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in AVXL in Q4 2022 and held it in 6 quarters. The position peaked at $7.13K in Q4 2022. 140 funds tracked by Wall St. Rank hold AVXL as of Q2 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Anavex Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 748 Anavex Life Sciences shares in Q2 2024, an estimated $3.81K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Anavex Life Sciences in Q4 2022 and held it in 6 quarters.
  • Oliver Lagore Vanvalin Investment Group's Anavex Life Sciences position peaked at $7.13K in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2024, filed 15 Aug 2024.